Piper Sandler analyst David Westenberg lowered the firm’s price target on Exact Sciences (EXAS) to $75 from $85 following quarterly results. The firm keeps an Overweight rating on the shares.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Exact Sciences price target lowered to $70 from $75 at Wells Fargo
- Trump Media, broader market surge after Trump wins election: Morning Buzz
- Morning Movers: CVS Health surges and ODP sinks following Q3 results
- Exact Sciences price target lowered to $65 from $82 at Craig-Hallum
- Exact Sciences price target raised to $85 from $84 at Jefferies